• Doxorubicin Hydrochloride: Mechanism & Research

  2026-09-02

  Doxorubicin hydrochloride, also called Adriamycin HCl, is an anthracycline DNA topoisomerase II inhibitor used in cancer chemotherapy research. Its research value comes from reproducible DNA damage and cytotoxicity, while its cardiac effects support mechanistic cardiotoxicity models.

• Tacalcitol monohydrate: Applied Research Workflows

  2026-09-02

  Tacalcitol monohydrate connects VDR-centered gene regulation with practical keratinocyte, NGF, and colorectal cancer assays. This workflow-focused guide covers concentration selection, 5-fluorouracil combination studies, controls, storage, and a cautious way to adapt metabolomics and docking concepts from thrombosis research.

• Caspase-3 Fluorometric Assay Kit in Ferroptosis

  2026-09-01

  The Caspase-3 Fluorometric Assay Kit provides a direct activity readout for studying apoptosis within ferroptosis–apoptosis crosstalk. This guide explains how to interpret DEVD-dependent fluorescence alongside PARP1 and redox evidence for stronger mechanistic conclusions.

• Toremifene and the ER–Calcium Metastasis Axis

  2026-08-31

  Toremifene offers translational researchers more than an estrogen receptor tool: it can anchor a mechanism-first investigation into how hormone context intersects with calcium-dependent metastatic behavior in prostate cancer models. This framework connects selective estrogen-receptor modulation with the TSPAN18–STIM1–Ca2+ axis while clearly separating established findings from testable hypotheses.

• Leucomycin (Kitasamycin): From MIC to rRNA

  2026-08-31

  Leucomycin (kitasamycin) is a multi-component macrolide for connecting bacterial growth inhibition with 23S rRNA resistance biology. This guide develops a resistance-aware assay framework grounded in experimental swine dysentery data and practical research workflows.

• Substrate Stiffness and Dentinogenesis via LAMB1–FAK

  2026-08-30

  Bai and colleagues show that substrate stiffness promotes odontoblast-like cell extension and dentinogenic activity through a LAMB1–FAK–MEK1/2 signaling axis. The study connects a defined cell–material mechanical cue with extracellular-matrix signaling and provides a mechanistic framework for designing substrates for reparative dentin research.

• WM-8014: From KAT6A Biology to Translational Insight

  2026-08-29

  WM-8014 offers translational researchers a reversible, competitive way to interrogate KAT6A/B-driven chromatin regulation, senescence, and tumor growth arrest. This article connects its biochemical profile with MEF and zebrafish evidence, then shows how time-gated functional genomics such as RESTRICT-seq can turn an epigenetic dependency into a more rigorous validation strategy.

• Annexin V-PE Reagent for Early Apoptosis

  2026-08-29

  Annexin V-PE Reagent detects phosphatidylserine externalization as an early apoptosis marker through a rapid, calcium-dependent staining workflow. The K2280 product supports one-step labeling for flow cytometry apoptosis detection or fluorescence microscopy after 15–30 minutes.

• Aurora A Overexpression in Retinoblastoma

  2026-08-28

  A 2024 American Journal of Pathology study identifies Aurora kinase A as an overexpressed and clinically relevant vulnerability in retinoblastoma. By combining patient-tissue profiling with genetic depletion, pharmacologic inhibition, patient-derived material, and xenograft experiments, the work connects AURKA activity with high-risk pathology and MYCN regulation.

• SIS3: A Causal Assay Framework for Smad3

  2026-08-28

  SIS3, a selective Smad3 inhibitor, can help separate Smad3-dependent transcription from broader TGF-β responses. This article translates osteoarthritis evidence into a practical framework for designing fibrosis, renal, and cartilage assays with stronger causal interpretation.

• Annexin V Workflow for Apoptosis Assays

  2026-08-27

  Annexin V, human recombinant, provides a flexible phosphatidylserine binding protein platform for apoptosis detection, custom labeling, and competition studies. This workflow combines calcium-dependent assay design with reference-informed controls and troubleshooting for more reproducible cell death research.

• Erastin Workflow for Ferroptosis Research

  2026-08-27

  Erastin is a practical ferroptosis inducer for probing cystine depletion, glutathione loss, and oxidative tumor-cell vulnerability. This workflow connects mutation-aware cell selection with redox readouts and an evidence-based strategy for examining ABCB1-linked docetaxel resistance.

• Protease Inhibitor Cocktail: MS-SAFE Workflow

  2026-08-26

  Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) supports protein degradation prevention during cell and tissue extraction, including workflows intended for mass spectrometry. It should be added during lysis and used with cold, rapid handling; it is not a complete metalloproteinase solution unless separately supplemented with EDTA, and it may not suit workflows that specifically require AEBSF.

• Bradykinin BA5201: Vascular Assay Workflows

  2026-08-26

  Learn how to use Bradykinin as an endothelium-dependent vasodilator for vascular permeability modulation, contractility, and inflammation studies. This workflow-driven guide also translates the reference study’s multimodal design into practical controls, readouts, and troubleshooting decisions without overstating cross-domain evidence.

• TG003 Cdc2-like Kinase Inhibitor Workflow

  2026-08-25

  TG003 combines nanomolar biochemical activity against selected Clk isoforms with practical utility in alternative splicing, exon-skipping, and platinum-resistance studies. This guide translates its kinase and splicing pharmacology into controlled cell workflows, assay-selection logic, and troubleshooting steps.

453 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page